Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 1;59(11):1650-1.
doi: 10.1093/cid/ciu648. Epub 2014 Aug 13.

Mortality in patients with AIDS-related cytomegalovirus retinitis in Myanmar

NiNi Tun  1 , Frank M Smithuis  2 , Nikolas London  3 , W Lawrence Drew  4 , David Heiden  5
Affiliations

Mortality in patients with AIDS-related cytomegalovirus retinitis in Myanmar

NiNi Tun et al. Clin Infect Dis. .
No abstract available

PubMed Disclaimer

References

    1. Yust I, Fox Z, Burke M, et al. Retinal and extra ocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001. Eur J Clin Microbiol Infect Dis. 2004;23:550–9. - PubMed
    1. Brantsaeter AB, Liestel K, Goplen AK, Dunlop O, Bruun JN. CMV disease in AIDS patients: incidence of CMV disease and relation to survival in a population-based study from Oslo. Scand J Infect Dis. 2002;34:50–5. - PubMed
    1. Deayton JR, Sabin CA, Johnson MA, et al. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet. 2004;363:2116–21. - PubMed
    1. Jabs DA, Ahuja A, Van Natta M, Dunn JP, Yeh S for the Studies of the Ocular Complications of AIDS Research Group. Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology. 2013;120:1262–70. - PMC - PubMed
    1. Teoh SC, Ou X, Lim TH. Intravitreal ganciclovir maintenance injection for cytomegalovirus retinitis: efficacy of a low-volume, intermediate-dose regimen. Ophthalmology. 2012;119:588–95. - PubMed

MeSH terms